Changes in lipid profile during pregnancy and their association with metabolic disorders

Authors

  • María José Aguilar Cordero Departamento de enfermería, Facultad de Ciencias de la Salud, Universidad de Granada. España. Grupo de investigación CTS 367 (PAI). España.
  • María Quirantes Morillas Hospital Príncipe de Asturias. Alcalá de Henares. Madrid. España.
  • Tania Rivero Blanco Grupo de investigación CTS 367 (PAI). España.
  • Ana María Rojas Carvajal Grupo de investigación CTS 367 (PAI). España.
  • Íñigo María Pérez Castillo Grupo de investigación CTS 367 (PAI). España.
  • Antonio Manuel Sánchez López Grupo de investigación CTS 367 (PAI). España.

DOI:

https://doi.org/10.19230/jonnpr.4008

Abstract

Background. Various changes occur during  regnancy that, when exacerbated, could progress  to metabolic and cardiovascular disorders such as gestational hypertension, hyperlipidemia, and gestational diabetes mellitus.

Objective. To conduct a systematic review of the literature that evaluates the association between changes in lipid profile during pregnancy and the risk of developing metabolic and cardiovascular disorders.

Methods. We conducted a PRISMA systematic review of scientific databases. A total of 22 articles were finally included. Used search terms consisted of lipid profile biomarkers (HDL, LDL, triglycerides, total cholesterol) in combination with the most important metabolic and cardiovascular disorders. Language was restricted to Spanish and English. The review was conducted during 2019.

Results. High levels of total cholesterol, LDL and triglycerides during pregnancy were found to be associated with increased risk of developing preeclampsia and gestational diabetes mellitus. Higher pre-gestational BMI and elevated gestational weight gain were associated with increase rates of hyperlipidemia which is closely related to vascular pathologies.

Conclusions. Fostering routine control of maternal weight during all trimesters of gestation and monitoring the lipid profile throughout pregnancy is necessary to prevent pregnancy adverse outcomes. New studies focused on specific perinatal outcomes such as neonatal macrosomia are required.

 

Downloads

Download data is not yet available.

References

Aguilar MJ, Baena L, Sánchez AM, Guisado R, Hermoso E, Mur N, et al. Nivel de triglicéridos como factor de riesgo durante el embarazo: modelado biológico; revisión sistemática. Nutr Hosp. 2015;32(2):517–27.

Trends in maternal mortality 2000 to 2017: estimates by WHO, UNICEF, UNFPA, World Bank Group and the United Nations Population Division. Geneva: World Health Organization; 2019.

Charlton F, Tooher J, Rye K-A, Hennessy A. Cardiovascular Risk, Lipids and Pregnancy: Preeclampsia and the Risk of Later Life Cardiovascular Disease. Hear Lung Circ . 2014;23(3):203–12.

Sesmero JR, Muñoz P, Solano AM, Odriozola JM, González M, Puertas A, et al. Mortalidad materna en España en el periodo 2010-2012: resultados de la encuesta de la Sociedad Española de Ginecología (SEGO). Progresos Obstet y Ginecol. 2015.

Ryckman K, Spracklen C, Smith C, Robinson J, Saftlas A. Maternal lipid levels during pregnancy and gestational diabetes: a systematic review and meta-analysis. BJOG An Int J Obstet Gynaecol. 2015;122(5):643–51.

Hutton B, Catalá-López F, Moher D. The PRISMA statement extension for systematic reviews incorporating network meta-analysis: PRISMA-NMA. Med Clin. 2016; 147(6):262–6.

Li Y, He J, Zeng X, Zhao S, Wang X, Yuan H. Non-fasting lipids detection and their significance in pregnant women. Lipids in Health and Disease. 2019;96(18).

Petry CJ, Koulman A, Lu L, Jenkins B, Furse S, Prentice P, et al. Associations between the maternal circulating lipid profile in pregnancy and fetal imprinted gene alleles: a cohort study. Reprod Biol Endocrinol. 2018;16(1):82.

Bugatto F, Quintero R, Visiedo FM, Vilar JM, Figueroa A, López-Tinoco C, et al. The Influence of Lipid and Proinflammatory Status on Maternal Uterine Blood Flow in Women With Late Onset Gestational Diabetes. Reprod Sci. 2018;25(6):837–43.

Ghodke B, Pusukuru R, Mehta V. Association of Lipid Profile in Pregnancy with Preeclampsia, Gestational Diabetes Mellitus, and Preterm Delivery. Cureus. 2017.

Keshavarz P, Nobakht M. Gh BF, Mirhafez SR, Nematy M, Azimi M, Afin SA, et al. Alterations in Lipid Profile, Zinc and Copper Levels and Superoxide Dismutase Activities in Normal Pregnancy and Preeclampsia. Am J Med Sci. 2017;353(6):552–8.

Van Lieshout N, Oostvogels AJJM, Gademan MGJ, Vrijkotte TGM. Maternal early pregnancy lipid profile and offspring’s lipids and glycaemic control at age 5–6 years: The ABCD study. Clin Nutr. 2017;36(6):1628–34.

Lekva T, Michelsen AE, Aukrust P, Paasche MC, Henriksen T, Bollerslev J, et al. CXC chemokine ligand 16 is increased in gestational diabetes mellitus and preeclampsia and associated with lipoproteins in gestational diabetes mellitus at 5 years follow-up. Diabetes Vasc Dis Res. 2017;14(6):525–33.

Revankar VM, Narmada L. Assessment of serum ?-hCG and lipid profile in early second trimester as predictors of hypertensive disorders of pregnancy. Int J Gynecol Obstet. 2017;138(3):331–4.

Badillo P, Salgado P, Bravo P, Guevara K, Acurio J, Gonzalez MA, et al. High plasma adenosine levels in overweight/obese pregnant women. Purinergic Signal [Internet]. 2017;13(4):479–88.

Vidakovic AJ, Jaddoe VWV, Voortman T, Demmelmair H, Koletzko B, Gaillard R. Maternal plasma polyunsaturated fatty acid levels during pregnancy and childhood lipid and insulin levels. Nutr Metab Cardiovasc Dis. 2017;27(1):78-85.

Geraghty AA, Alberdi G, O’Sullivan EJ, O’Brien EC, Crosbie B, Twomey PJ, et al. Maternal and fetal blood lipid concentrations during pregnancy differ by maternal body mass index: findings from the ROLO study. Pregnancy and ChildbirthBMC. 2017; 17(1):360.

Shen H, Liu X, Chen Y, HE B, Cheng W. Associations of lipid levels during gestation with hypertensive disorders of pregnancy and gestational diabetes mellitus: a prospective longitudinal cohort study. BMJ Open. 2016;6(12):e013509.

Ryckman KK, Spracklen CN, Smith CJ, Robinson JG, Saftlas AF. Maternal lipids levels during pregnancy and gestational diabetes: a systematic review and meta-analysis. BJOG. 2015;122(5).

Bever AM, Mumford SL, Schisteman EF, Sjaarda L, Perkins NJ, Gerlanc N et al., Maternal preconception lipid profile and gestational lipid changes in relation to birthweight outcomes. Scientific Reports. 2020;1374(10)

Jin W-Y, Lin S-L, Hou R-L, Chen X-Y, Han T, Jin Y, et al. Associations between maternal lipid profile and pregnancy complications and perinatal outcomes: a population-based study from China. BMC Pregnancy Childbirth. 2016;16(1):60.

Bartels A and O’Donoghue K. Cholesterol in pregnancy: a review of knowns and unknowns. Obstetric Medicine. 2011;(4):147-151

Barrett HL, Dekker Nitert M, D’Emden M, McIntyre HD, Callaway LK. Validation of a triglyceride meter for use in pregnancy. BMC Res Notes. 2014;7(1):679.

Vinter CA, Jørgensen JS, Ovesen P, Beck-Nielsen H, Skytthe A, Jensen DM. Metabolic effects of lifestyle intervention in obese pregnant women. Results from the randomized controlled trial ‘Lifestyle in Pregnancy’ (LiP). Diabet Med. 2014; 31(11):1323–30.

Ephraim R, Doe P, Amoah S, Antoh E. Lipid profile and high maternal body mass index is associated with preeclampsia: A case-control study of the Cape Coast Metropolis. Ann Med Health Sci Res. 2014;4(5):746.

Emet T, Üstüner I, Güven SG, Bal?k G, Ural ÜM, Tekin YB, et al. Plasma lipids and lipoproteins during pregnancy and related pregnancy outcomes. Arch Gynecol Obstet. 2013;288(1):49–55.

Scifres CM, Catov JM, Simhan HN. The impact of maternal obesity and gestational weight gain on early and mid-pregnancy lipid profiles. Obesity. 2014;22(3):932–8.

Fraser A, Nelson SM, Macdonald-Wallis C, Cherry L, Butler E, Sattar N, et al. Associations of Pregnancy Complications With Calculated Cardiovascular Disease Risk and Cardiovascular Risk Factors in Middle Age. Circulation. 2012;125(11):1367–80.

Saxena S, Thimmaraju K, Srivastava P, Mallick A, Das B, Sinha N, et al. Role of dyslipidaemia and lipid peroxidation in pregnancy induced hypertension. J Clin Sci Res. 2015;4(3):205.

Mankuta D, Elami-Suzin M, Elhayani A, Vinker S. Lipid profile in consecutive pregnancies. Lipids Health Dis. 2010;9(1):58.

Lekva T, Bollerslev J, Norwitz ER, Aukrust P, Henriksen T, Ueland T. Aortic Stiffness and Cardiovascular Risk in Women with Previous Gestational Diabetes Mellitus. Sanchez-Margalet V, editor. PLoS One. 2015;10(8).

Vrijkotte TGM, Krukziener N, Hutten BA, Vollebregt KC, van Eijsden M, Twickler MB. Maternal Lipid Profile During Early Pregnancy and Pregnancy Complications and Outcomes: The ABCD Study. J Clin Endocrinol Metab. 2012;97(11):3917–25.

Poveda NE, Garcés MF, Ruiz-Linares CE, Varón D, Valderrama S, Sanchez E, et al. Serum Adipsin Levels throughout Normal Pregnancy and Preeclampsia OPEN. Nat Publ Gr. 2016;6:20073.

Nouhjah S, Shahbazian H, Jahanfar S, Shahbazian N, Jahanshahi A, Cheraghian B, et al. Early Postpartum Lipid Profile in Women with and Without Gestational Diabetes Mellitus: Results of a Prospective Cohort Study. Iran Red Crescent Med J. 2017;19(6).

Blagoeva V, Arevalo J, Antolin E & García-Tizón S. Maternal mortality in Spain and its association with country of origin: cross-sectional study during the period 1999–2015. BMC Public Health. 2018;18:1171.

Published

2021-05-08